All-inclusive CRISPRevolution EZ sgRNA Kit makes fast, high quality gene editing
accessible to researchers worldwide
 
Synthego, a leading provider of genome engineering solutions, today announces the world’s first synthetic single guide RNA (sgRNA) CRISPR genome editing kit. Synthego’s 100-nucleotide sgRNA is the critical component of the new kit already in use by several dozen world-class pharmaceutical and industry organizations, and research
institutions such as the Seattle Children’s Research Institute and the University of California, Berkeley, Patel Lab. Offered under its CRISPRevolution portfolio, the sgRNA ships within 5 days ready-for-transfection, is 100 percent DNA-free and requires no annealing, saving additional time and money. In addition to enabling superior editing efficiencies, Synthego delivers sgRNA to researchers faster and at a lower price than alternatives.
 
Prior to CRISPRevolution, synthetic sgRNA required several weeks for production, was expensive, and lacked scalability to high throughput due to required custom processes. With Synthego’s high-precision automated...
 
Researchers at UC Berkeley are also using Synthego’s sgRNA kit with high success rates. “I tried Synthego’s synthetic sgRNA for the first time for CRISPR knock-out, and my survival rate was much higher than using IVT guides,” said Erin Jarvis, PhD candidate, Evolutionary Development Biology, UC Berkeley’s Patel Lab. “So far, every crustacean embryo I’ve checked has been transformed. You can’t get much better than that.”
 
The CRISPRevolution EZ sgRNA Kit includes:
  • Target-Specific Synthetic sgRNA (100 nucleotides)
  • Cas9 2NLS Nuclease (Optional)
  •  Tris-EDTA buffer
  •  Nuclease-free ultra-pure water
List price for the Synthego sgRNA kit starts at $295 per gene target, with special discounts for
academic research and volume purchases. For more information on Synthego visit:
 
About Synthego
Founded by former SpaceX engineers, Synthego is a leading provider of genome engineering
solutions. The company's flagship product, CRISPRevolution, is a portfolio of synthetic RNA
designed for CRISPR genome editing and research. Synthego’s vision is to bring precision and
automation to genome engineering, enabling rapid and cost-effective research with consistent
results for every scientist. Headquartered in Silicon Valley, California, Synthego customers
include leading institutions around the world including countries such as Australia, Belgium,
Germany, UK, USA and Switzerland.

 

Interested in reading more?

The Scientist ARCHIVES

Become a Member of

Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?